Endometrial Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are between 18 and 80 years old
- You are generally able to carry out daily activities and care for yourself (your doctor will assess this using a standard scale)
- You have been diagnosed with endometrial (uterine) cancer of a specific type (endometrioid, serous, clear cell, or carcinosarcoma) at a certain stage, and your doctors have recommended radiation treatment to the pelvic area after surgery based on your test and tissue results
- You may still be eligible even if your treatment plan also includes chemotherapy and/or internal radiation (brachytherapy)
- You are willing and able to sign a consent form agreeing to take part in the study
Who may not be able to join:
- You have had radiation treatment to the pelvic area in the past
- Your cancer has spread to lymph nodes near the large blood vessel in your abdomen (called the aorta)
- You are significantly limited in your ability to care for yourself or carry out daily activities (confirm with trial site)
- You have been diagnosed with inflammatory bowel disease (such as Crohn's disease or ulcerative colitis), whether it is currently active or not
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +393334393336
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Acute G3 or higher Gastrointestinal and Genitourinary Toxicity
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.